| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |